IMVT
Immunovant, Inc. · Healthcare
CEO Peter Salzmann sold $150K of Immunovant, Inc.
Sold$149,882
$31.18Price
4,807Shares
What IMVT did after the filing
- The stock from Wed, Apr 10 close, $30.88
- −4.3%
- S&P 500, same days
- +3.1%
Measured over 30 trading days, to the May 22 close.
Traded Tue, Apr 9. Filed Wed, Apr 10, 12:14 PM ET, during the session. Returns use the Apr 10 close and the May 22 close. Not investment advice.